The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Rashmi Kothary

person-rashmi-kothary

Deputy Scientific Director and Senior Scientist, Ottawa Hospital Research Institute

Professor, University of Ottawa

Email Rashmi

Read more about Rashmi

Biography

Dr Rashmi Kothary is the Deputy Scientific Director and Senior Scientist at the Ottawa Hospital Research Institute (OHRI). He received a Ph.D. in Biochemistry from the University of British Columbia and pursued postdoctoral research in the laboratories of Dr. Janet Rossant at the Mount Sinai Hospital Research Institute in Toronto and Dr. Azim Surani in Cambridge, U.K. It was during these formative years that Dr. Kothary developed his interests in pre-clinical models to study disease pathology. In 1990, he returned to Canada to begin his independent research career at the Institut du cancer de Montréal. In 1998, Dr. Kothary joined the Ottawa Hospital Research Institute. He has held the University Health Research Chair in Neuromuscular Disorders and is a Professor at the University of Ottawa. His current research focuses on investigating extrinsic and intrinsic factors important for oligodendrocyte mediated myelination and remyelination of the CNS (in the context of Multiple Sclerosis), and understanding Spinal Muscular Atrophy pathogenesis and identifying novel therapeutics for this devastating children’s disease. He currently sits on the CIHR IMHA advisory board, has served on the scientific advisory board for MDA and Cure SMA, and is a reviewer for the CIHR, NIH and Shriners Hospitals for Children.

Dr. Kothary represents basic science as a member of the NMD4C Steering Committee.

Recent publications

Deguise, MO, Pileggi, C, De Repentigny, Y, Beauvais, A, Tierney, A, Chehade, L et al.. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease. Cell Mol Gastroenterol Hepatol. 2021. PMID:33545428

Warman-Chardon, J, Jasmin, BJ, Kothary, R, Parks, RJ. Report on the 5th Ottawa International Conference on Neuromuscular Disease & Biology -October 17-19, 2019, Ottawa, Canada. J Neuromuscul Dis. 2021.8 (2)323-334 PMID:33492242

Lynch-Godrei, A, De Repentigny, Y, Ferrier, A, Gagnon, S, Kothary, R. Dystonin loss-of-function leads to impaired autophagy-endolysosomal pathway dynamics. Biochem Cell Biol. 2020. PMID:33347391

Pringle, CE, Nelson, R, Miller, W, Kothary, R, Michaud, J. Spinal muscular atrophy type III complicated by spinal superficial siderosis: a case report with molecular and neuropathological findings. Acta Neuropathol Commun. 2020.8 (1)188 PMID:33168084

Kosaraju, J, Seegobin, M, Gouveia, A, Syal, C, Sarma, SN, Lu, KJ et al.. Metformin promotes CNS remyelination and improves social interaction following focal demyelination through CBP Ser436 phosphorylation. Exp Neurol. 2020.334 113454 PMID:32877653

See more on PubMed